$OLKR
OpenLocker Holdings, Inc. Stock $olkr

$olkr Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223045064 Filed on December 15, 2023

Income Statement

Concept	2023 Q4	2022 Q4
Revenue	$8.581K	$5.140K
YoY Change	66.95%
Cost Of Revenue	$916.00
YoY Change
Gross Profit	$7.665K	$5.140K
YoY Change	49.12%
Gross Profit Margin	89.33%	100.0%
Selling, General & Admin	$458.1K	$498.3K
YoY Change	-8.07%	-80.53%
% of Gross Profit	5976.78%	9694.94%
Research & Development	$14.25K	$72.52K
YoY Change	-80.35%
% of Gross Profit	185.9%	1410.93%
Depreciation & Amortization	$790.00	$82.92K
YoY Change	-99.05%	10396.2%
% of Gross Profit	10.31%	1613.23%
Operating Expenses	$473.2K	$570.8K
YoY Change	-17.11%	-77.7%
Operating Profit	-$465.5K	-$565.7K
YoY Change	-17.71%	-77.9%
Interest Expense	$6.475K
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$6.475K
YoY Change
Pretax Income	-$472.0K	-$565.7K
YoY Change	-16.57%	-77.9%
Income Tax
% Of Pretax Income
Net Earnings	-$472.0K	-$565.7K
YoY Change	-16.57%	-77.9%
Net Earnings / Revenue	-5500.21%	-11005.95%
Basic Earnings Per Share	-$0.01	-$0.01
Diluted Earnings Per Share	-$0.01	-$0.01
COMMON SHARES
Basic Shares Outstanding	41.38M shares	38.64M shares
Diluted Shares Outstanding	41.32M shares	38.53M shares

Balance Sheet

Concept	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$50.54K	$405.6K
YoY Change	-87.54%	1928.1%
Cash & Equivalents	$50.54K	$405.6K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables	$0.00
Total Short-Term Assets	$50.54K	$405.6K
YoY Change	-87.54%	1928.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.109K	$5.277K
YoY Change	-60.03%	-47.23%
Goodwill		$2.944M
YoY Change
Intangibles		$2.163M
YoY Change
Long-Term Investments		$15.00K
YoY Change		50.0%
Other Assets
YoY Change
Total Long-Term Assets	$2.109K	$5.130M
YoY Change	-99.96%	16998.63%
TOTAL ASSETS
Total Short-Term Assets	$50.54K	$405.6K
Total Long-Term Assets	$2.109K	$5.130M
Total Assets	$52.65K	$5.535M
YoY Change	-99.05%	10970.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$102.0K	$99.70K
YoY Change	2.29%	398.5%
Accrued Expenses	$0.00	$4.820K
YoY Change	-100.0%	-91.97%
Deferred Revenue	$4.050K
YoY Change
Short-Term Debt	$230.0K	$0.00
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$336.0K	$104.5K
YoY Change	221.5%	-56.45%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$336.0K	$104.5K
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$336.0K	$104.5K
YoY Change	221.5%	-56.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.61M	-$3.274M
YoY Change	223.96%
Common Stock	$4.142K	$3.864K
YoY Change	7.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$283.4K	$5.431M
YoY Change
Total Liabilities & Shareholders Equity	$52.65K	$5.535M
YoY Change	-99.05%	10970.41%

Cashflow Statement

Concept	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$472.0K	-$565.7K
YoY Change	-16.57%	-77.9%
Depreciation, Depletion And Amortization	$790.00	$82.92K
YoY Change	-99.05%	10396.2%
Cash From Operating Activities	-$195.0K	-$259.6K
YoY Change	-24.89%	-186.55%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$230.0K	$58.12K
YoY Change	295.76%
NET CHANGE
Cash From Operating Activities	-$195.0K	-$259.6K
Cash From Investing Activities
Cash From Financing Activities	$230.0K	$58.12K
Net Change In Cash	$35.00K	-$201.5K
YoY Change	-117.37%
FREE CASH FLOW
Cash From Operating Activities	-$195.0K	-$259.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--07-31
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0000924396
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022Q4	us-gaap	Interest Expense InterestExpense		usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties		usd
CY2022Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q4	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2022Q3	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
CY2022Q3	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Grant Date Exercisable Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateExercisableFairValue
CY2023	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalIntrinsicValue		usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodTotalIntrinsicValue		usd
CY2023	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingForfeitedWeightedAverageGrantDateFairValue
CY2023Q3	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
CY2023Q3	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Grant Date Exercisable Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateExercisableFairValue
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q4	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023Q4	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q4	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodTotalIntrinsicValue		usd
CY2023Q4	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingForfeitedWeightedAverageGrantDateFairValue
CY2023Q4	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
CY2023Q4	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Grant Date Exercisable Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateExercisableFairValue
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares		shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023Q4	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedIntrinsicValue1		usd
CY2023Q4	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Grant Date Unvested Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateUnvestedFairValue
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber		shares
CY2022Q3	OLKR	Share Based Compensation Arrangement By Share Based Payment Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
CY2022Q3	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue		usd
CY2022Q3	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber		shares
CY2022Q3	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
CY2022Q3	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableIntrinsicValue1		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023	OLKR	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	OLKR	Share Based Compensation Arrangeme Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangemeShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations		shares
CY2023	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q3	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue		usd
CY2023Q3	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableIntrinsicValue1		usd
CY2023Q4	OLKR	Share Based Compensation Arrangement Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023Q4	OLKR	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023Q4	OLKR	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4	OLKR	Share Based Compensation Arrangeme Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangemeShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations		shares
CY2023Q4	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q4	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue		usd
CY2023Q4	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableIntrinsicValue1		usd
CY2023Q4	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedNumberOfShares		shares
CY2023Q4	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023Q4	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Unvested Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsUnvestedIntrinsicValue1		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
CY2023Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q4	dei	Document Type DocumentType	10-Q
CY2023Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	dei	Document Period End Date DocumentPeriodEndDate	2023-10-31
CY2023Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	dei	Entity File Number EntityFileNumber	000-24520
CY2023Q4	dei	Entity Registrant Name EntityRegistrantName	OpenLocker Holdings, Inc.
CY2023Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3021770
CY2023Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	1700 Palm Beach Lakes Blvd.
CY2023Q4	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 820
CY2023Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
CY2023Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
CY2023Q4	dei	City Area Code CityAreaCode	(305)
CY2023Q4	dei	Local Phone Number LocalPhoneNumber	351-9195
CY2023Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41479650	shares
CY2023Q4	us-gaap	Cash Cash	50537	usd
CY2023Q3	us-gaap	Cash Cash	15539	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	50537	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	23539	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2109	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2901	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	278	usd
CY2023Q4	us-gaap	Assets Assets	52646	usd
CY2023Q3	us-gaap	Assets Assets	26718	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4050	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10050	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	498	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	336033	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	124394	usd
CY2023Q4	us-gaap	Liabilities Liabilities	336033	usd
CY2023Q3	us-gaap	Liabilities Liabilities	124394	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	5	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	5	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41379650	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41379650	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40675006	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40675006	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4142	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	4071	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10318526	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10032335	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10606060	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10134087	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-283387	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-97676	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52646	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26718	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8581	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5140	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	916	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	7665	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	5140	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14249	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	72522	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	458914	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	498324	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	473163	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	570846	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-465498	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-565706	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	6475	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6475	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-471973	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-565706	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41321999	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41321999	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38527805	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38527805	shares
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-97676	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	202679	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	83583	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-471973	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-283387	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	5719109	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	167167	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	52000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	6000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2116	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-565706	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5430686	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-471973	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-565706	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	82126	usd
CY2023Q4	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	792	usd
CY2022Q4	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	792	usd
CY2023Q4	OLKR	Operating Lease Right Of Use Asset Related Party Amortization Expense OperatingLeaseRightOfUseAssetRelatedPartyAmortizationExpense	278	usd
CY2022Q4	OLKR	Operating Lease Right Of Use Asset Related Party Amortization Expense OperatingLeaseRightOfUseAssetRelatedPartyAmortizationExpense	838	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	83583	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	167167	usd
CY2023Q4	OLKR	Issuance Of Stock And Warrants For Services IssuanceOfStockAndWarrantsForServices	-202679	usd
CY2022Q4	OLKR	Issuance Of Stock And Warrants For Services IssuanceOfStockAndWarrantsForServices	-52000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-14008	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4532	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	2145	usd
CY2023Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6000	usd
CY2023Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-498	usd
CY2022Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1385	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-195002	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-259636	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	6000	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	usd
CY2022Q4	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	2116	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	230000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	58116	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34998	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-201520	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15539	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	607135	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	50537	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	405615	usd
CY2023Q4	us-gaap	Interest Paid Net InterestPaidNet	1440	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-471973	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-195002	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10606060	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-283387	usd
CY2023Q4	OLKR	Working Capital Deficit WorkingCapitalDeficit	285496	usd
CY2023Q4	us-gaap	Cash Cash	50537	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	479539	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1478050	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.14
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.68
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zniYde5EXrlf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_z2q11XZPCV4f">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2943874	usd
CY2023Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1916270	usd
CY2023Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2342539	shares
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4050	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10050	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8581	usd
CY2023Q4	OLKR	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5140	usd
CY2022Q4	OLKR	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.49
CY2023Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	32004	usd
CY2022Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	44048	usd
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	62182539	shares
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	45630830	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y11M23D
CY2023Q4	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z3T5kYpnJ6fd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_z79K5qWHf6n">Reclassifications</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications had no material effect on the unaudited consolidated results of operations, stockholders’ deficit, or cash flows.</span></p>
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10836	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10836	usd
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8727	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7935	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2109	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2901	usd
CY2023Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	792	usd
CY2022Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	792	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	142029	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2219368	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.48
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1425000	shares
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	1916270	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	82126	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	864489	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.14
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y10M2D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	479539	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	864489	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.14
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y10M2D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y11M23D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	142029	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2342539	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.49
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y8M23D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	63159	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2342539	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.49
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y8M23D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	63159	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	123171	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1478050	shares
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.40
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1003002	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.74	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0298	pure
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	83583	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	167167	usd
CY2023	OLKR	Share Based Compensation Arrangement Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	1425000	shares
CY2023	OLKR	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	1.00
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1425000	shares
CY2023Q3	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	1.00
CY2023	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y7M28D
CY2023Q3	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	1425000	shares
CY2023Q3	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	1.00
CY2023	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M28D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1425000	shares
CY2023Q4	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	1.00
CY2023Q4	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M28D
CY2023Q4	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	1425000	shares
CY2023Q4	OLKR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	1.00
CY2023Q4	OLKR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M28D
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P2Y
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	500	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	7500	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	278	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	498	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y29D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	278	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	838	usd
CY2023Q4	OLKR	Lease Liability Expense In Connection With Obligation Repayment LeaseLiabilityExpenseInConnectionWithObligationRepayment	3	usd
CY2022Q4	OLKR	Lease Liability Expense In Connection With Obligation Repayment LeaseLiabilityExpenseInConnectionWithObligationRepayment	115	usd
CY2023Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	281	usd
CY2022Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	953	usd
CY2023Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	498	usd
CY2022Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	1385	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-23-045064-index-headers.html	Edgar Link	pending
0001493152-23-045064-index.html	Edgar Link	pending
0001493152-23-045064.txt	Edgar Link	pending
0001493152-23-045064-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
olkr-20231031.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
olkr-20231031_cal.xml	Edgar Link	unprocessable
olkr-20231031_lab.xml	Edgar Link	unprocessable
olkr-20231031_def.xml	Edgar Link	unprocessable
olkr-20231031_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OLKR
OpenLocker Holdings, Inc. Stock $olkr

2023 Q4 Form 10-Q Financial Statement

#000149315223045064 Filed on December 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OLKR OpenLocker Holdings, Inc. Stock $olkr

2023 Q4 Form 10-Q Financial Statement

#000149315223045064 Filed on December 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OLKR
OpenLocker Holdings, Inc. Stock $olkr